Alyeska Investment Group’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-74,338
| Closed | -$247K | – | 596 |
|
2023
Q2 | $247K | Hold |
74,338
| – | – | ﹤0.01% | 458 |
|
2023
Q1 | $294K | Hold |
74,338
| – | – | ﹤0.01% | 404 |
|
2022
Q4 | $539K | Hold |
74,338
| – | – | 0.01% | 370 |
|
2022
Q3 | $269K | Hold |
74,338
| – | – | ﹤0.01% | 367 |
|
2022
Q2 | $337K | Hold |
74,338
| – | – | ﹤0.01% | 537 |
|
2022
Q1 | $563K | Sell |
74,338
-50,000
| -40% | -$379K | 0.01% | 541 |
|
2021
Q4 | $1.36M | Sell |
124,338
-300,300
| -71% | -$3.28M | 0.02% | 491 |
|
2021
Q3 | $5.49M | Sell |
424,638
-9,455
| -2% | -$122K | 0.07% | 305 |
|
2021
Q2 | $4.94M | Sell |
434,093
-8,219
| -2% | -$93.5K | 0.06% | 352 |
|
2021
Q1 | $4.92M | Sell |
442,312
-57,688
| -12% | -$642K | 0.06% | 324 |
|
2020
Q4 | $5.72M | Sell |
500,000
-4,000
| -0.8% | -$45.8K | 0.08% | 246 |
|
2020
Q3 | $5.22M | Buy |
+504,000
| New | +$5.22M | 0.08% | 255 |
|